Selected research
Market Outlook & Growth Opportunities
Global Coagulation Reagent Market Outlook and Growth Opportunities 2026
Market perspective
The global Coagulation Reagent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Coagulation Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Coagulation Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Coagulation Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Coagulation Reagent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Coagulation Reagent market include Transasia, Steellex, Sekisui, Sclavo, Rayto, Randox, Medirox and Haemonetics Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Coagulation Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Coagulation Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Coagulation Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coagulation Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.
Coagulation Reagent Segment by Company
Transasia
Steellex
Sekisui
Sclavo
Rayto
Randox
Medirox
Haemonetics Corporation
Coagulation Reagent Segment by Type
APTT
PT
FIB
Coagulation Reagent Segment by Application
Scientific Research
Medical Tests
Others
Coagulation Reagent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Coagulation Reagent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Coagulation Reagent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Coagulation Reagent significant trends, drivers, influence factors in global and regions.
6. To analyze Coagulation Reagent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coagulation Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Coagulation Reagent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coagulation Reagent industry.
Chapter 3: Detailed analysis of Coagulation Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Coagulation Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Coagulation Reagent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- APTT
- PT
- FIB
Applications
- Scientific Research
- Medical Tests
- Others
Companies covered
- Transasia
- Steellex
- Sekisui
- Sclavo
- Rayto
- Randox
- Medirox
- Haemonetics Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Coagulation Reagent Sales Value (2021-2032)
- 1.2.2 Global Coagulation Reagent Sales Volume (2021-2032)
- 1.2.3 Global Coagulation Reagent Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Coagulation Reagent Market Dynamics
- 2.1 Coagulation Reagent Industry Trends
- 2.2 Coagulation Reagent Industry Drivers
- 2.3 Coagulation Reagent Industry Opportunities and Challenges
- 2.4 Coagulation Reagent Industry Restraints
3 Coagulation Reagent Market by Company
- 3.1 Global Coagulation Reagent Company Revenue Ranking in 2025
- 3.2 Global Coagulation Reagent Revenue by Company (2021-2026)
- 3.3 Global Coagulation Reagent Sales Volume by Company (2021-2026)
- 3.4 Global Coagulation Reagent Average Price by Company (2021-2026)
- 3.5 Global Coagulation Reagent Company Ranking (2024-2026)
- 3.6 Global Coagulation Reagent Company Manufacturing Base and Headquarters
- 3.7 Global Coagulation Reagent Company Product Type and Application
- 3.8 Global Coagulation Reagent Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Coagulation Reagent Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Coagulation Reagent Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Coagulation Reagent Market by Type
- 4.1 Coagulation Reagent Type Introduction
- 4.1.1 APTT
- 4.1.2 PT
- 4.1.3 FIB
- 4.2 Global Coagulation Reagent Sales Volume by Type
- 4.2.1 Global Coagulation Reagent Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Coagulation Reagent Sales Volume by Type (2021-2032)
- 4.2.3 Global Coagulation Reagent Sales Volume Share by Type (2021-2032)
- 4.3 Global Coagulation Reagent Sales Value by Type
- 4.3.1 Global Coagulation Reagent Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Coagulation Reagent Sales Value by Type (2021-2032)
- 4.3.3 Global Coagulation Reagent Sales Value Share by Type (2021-2032)
5 Coagulation Reagent Market by Application
- 5.1 Coagulation Reagent Application Introduction
- 5.1.1 Scientific Research
- 5.1.2 Medical Tests
- 5.1.3 Others
- 5.2 Global Coagulation Reagent Sales Volume by Application
- 5.2.1 Global Coagulation Reagent Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Coagulation Reagent Sales Volume by Application (2021-2032)
- 5.2.3 Global Coagulation Reagent Sales Volume Share by Application (2021-2032)
- 5.3 Global Coagulation Reagent Sales Value by Application
- 5.3.1 Global Coagulation Reagent Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Coagulation Reagent Sales Value by Application (2021-2032)
- 5.3.3 Global Coagulation Reagent Sales Value Share by Application (2021-2032)
6 Coagulation Reagent Regional Sales and Value Analysis
- 6.1 Global Coagulation Reagent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Coagulation Reagent Sales by Region (2021-2032)
- 6.2.1 Global Coagulation Reagent Sales by Region: 2021-2026
- 6.2.2 Global Coagulation Reagent Sales by Region (2027-2032)
- 6.3 Global Coagulation Reagent Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Coagulation Reagent Sales Value by Region (2021-2032)
- 6.4.1 Global Coagulation Reagent Sales Value by Region: 2021-2026
- 6.4.2 Global Coagulation Reagent Sales Value by Region (2027-2032)
- 6.5 Global Coagulation Reagent Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Coagulation Reagent Sales Value (2021-2032)
- 6.6.2 North America Coagulation Reagent Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Coagulation Reagent Sales Value (2021-2032)
- 6.7.2 Europe Coagulation Reagent Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Coagulation Reagent Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Coagulation Reagent Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Coagulation Reagent Sales Value (2021-2032)
- 6.9.2 South America Coagulation Reagent Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Coagulation Reagent Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Coagulation Reagent Sales Value Share by Country, 2025 VS 2032
7 Coagulation Reagent Country-level Sales and Value Analysis
- 7.1 Global Coagulation Reagent Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Coagulation Reagent Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Coagulation Reagent Sales by Country (2021-2032)
- 7.3.1 Global Coagulation Reagent Sales by Country (2021-2026)
- 7.3.2 Global Coagulation Reagent Sales by Country (2027-2032)
- 7.4 Global Coagulation Reagent Sales Value by Country (2021-2032)
- 7.4.1 Global Coagulation Reagent Sales Value by Country (2021-2026)
- 7.4.2 Global Coagulation Reagent Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.9.2 France Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.16.2 China Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.19.2 India Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Coagulation Reagent Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Coagulation Reagent Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Coagulation Reagent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Transasia
- 8.1.1 Transasia Company Information
- 8.1.2 Transasia Business Overview
- 8.1.3 Transasia Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Transasia Coagulation Reagent Product Portfolio
- 8.1.5 Transasia Recent Developments
- 8.2 Steellex
- 8.2.1 Steellex Company Information
- 8.2.2 Steellex Business Overview
- 8.2.3 Steellex Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Steellex Coagulation Reagent Product Portfolio
- 8.2.5 Steellex Recent Developments
- 8.3 Sekisui
- 8.3.1 Sekisui Company Information
- 8.3.2 Sekisui Business Overview
- 8.3.3 Sekisui Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Sekisui Coagulation Reagent Product Portfolio
- 8.3.5 Sekisui Recent Developments
- 8.4 Sclavo
- 8.4.1 Sclavo Company Information
- 8.4.2 Sclavo Business Overview
- 8.4.3 Sclavo Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Sclavo Coagulation Reagent Product Portfolio
- 8.4.5 Sclavo Recent Developments
- 8.5 Rayto
- 8.5.1 Rayto Company Information
- 8.5.2 Rayto Business Overview
- 8.5.3 Rayto Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Rayto Coagulation Reagent Product Portfolio
- 8.5.5 Rayto Recent Developments
- 8.6 Randox
- 8.6.1 Randox Company Information
- 8.6.2 Randox Business Overview
- 8.6.3 Randox Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Randox Coagulation Reagent Product Portfolio
- 8.6.5 Randox Recent Developments
- 8.7 Medirox
- 8.7.1 Medirox Company Information
- 8.7.2 Medirox Business Overview
- 8.7.3 Medirox Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Medirox Coagulation Reagent Product Portfolio
- 8.7.5 Medirox Recent Developments
- 8.8 Haemonetics Corporation
- 8.8.1 Haemonetics Corporation Company Information
- 8.8.2 Haemonetics Corporation Business Overview
- 8.8.3 Haemonetics Corporation Coagulation Reagent Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Haemonetics Corporation Coagulation Reagent Product Portfolio
- 8.8.5 Haemonetics Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Coagulation Reagent Value Chain Analysis
- 9.1.1 Coagulation Reagent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Coagulation Reagent Sales Mode & Process
- 9.2 Coagulation Reagent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Coagulation Reagent Distributors
- 9.2.3 Coagulation Reagent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst